Dr Paul J Thornalley (PhD Biochemistry, University of Oxford, UK)
Dr Paul J Thornalley (PhD Biochemistry, University of Oxford, UK) is Scientific Director, Diabetes Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Doha, Qatar. He is a leading researcher in studies of the reactive glucose-derived metabolite, methylglyoxal, and its metabolism by glyoxalase 1 (Glo1) of the glyoxalase system – particularly in the development of insulin resistance and vascular complication of diabetes in which he is considered founding investigator. He originated the strategy for development of small molecule inducers of Glo1 expression or “Glo1 inducer” therapeutics for treatment of insulin resistance and microvascular complications of diabetes. His h-index is 105 with ca. 39,000 citations of his work.